ClinicalTrials.gg
Status unknownNCT04261764FASTARUpdated Oct 12, 2021

Fasting-mimicking Diet Combined With Traditional Chinese Medicine for Phlegm-dampness Type Obesity Patients

An interventional study of Fastening-mimicking diet combined with a "dispelling dampness" meal replacement and Normal diet in Obesity, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Status unknown at 2 sites in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-10-12.

Sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The primary aim of this study is to is to determine if a diet (TCM-FMD) which combine fasting-mimicking diet (FMD) with "dispelling dampness" meal replacement (a meal replacement made up of traditional Chinese medicine) is the effective dietary strategy for treatment of phlegm-dampness type overweight/obese patients. A three months randomized trial will be used to observe weight loss generated by TCM-FMD. And a group keeping a normal diet will be set as a blank control. Through comparison, we aim at examining the effects of interventions on weight and the diversity and abundance of intestinal flora .

Read the detailed description

Background: Fasting-mimicking Diet (FMD) is a plant-based diet designed to attain fasting-like effect, firstly proposed on 2015. It requires people to limit calorie intake for 5 continuous days, and then return to their normal diet after completion about 25 days until the next cycle. In a clinical trial, three FMD cycles reduced body weight, trunk and body fat, and reduced blood pressure, fasting blood glucose, triglycerides and total cholesterol. On the other hand, in the theory of physique of TCM theory, overweight/obesity is usually considered to be phlegm-dampness type.

Objective: We assume that using medicinal-edible plants which was considered to dispel dampness(such as fuling, shanyao, etc.) as FMD's proprietary formulations can enhance the effect of FMD on improve people's characteristic features of metabolic syndrome.

Methods: A 12-week, single-center, pilot study will be conducted to test the study objectives. A new diet is carried. It is a fasting-mimicking diet combined with a "dispelling dampness" meal replacement. Because the theory of applying traditional Chinese medicine combined with FMD, which one the main ingredient of the "dispelling dampness" meal package is Chinese Herbal Medicine such as shaoyao, yiyiren, and chixiaodou, etc. At the same time, a group of normal diets was also designed as a blank control group.

Outcomes: The primary outcome measure for the study was changes in the diversity and abundance of intestinal flora, the number of Firmicutes, Bacteroides and the ratio of Firmicutes/Bacteroides; secondary outcome measures included: weight, BMI, waist circumference, blood pressure, triglycerides, total cholesterol and fasting blood glucose, etc. Both groups were subjected to caloric restriction (5 days, daily calorie about 800kcal) and normal diet (dietitian for healthy diet guidance), and the blank control group was given a normal diet.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Obesity
  • Fasting-mimicking diet
  • Chinese medicine
03

In context

Obesity

6,583 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's planned enrollment of 40 is below the median of 77 across 5,091 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Guangdong Provincial Hospital of Traditional Chinese Medicine is the lead sponsor of 41 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed as overweight / obesity according to the "China Adult Obesity Prevention and Treatment Expert Consensus"
  • Diagnosis as phlegm-dampness type according to the "Traditional Chinese Medicine Classification and Judgment" scale published by the Chinese Medicine Association
  • 18 years old ≤ age ≤ 65 years old
  • Signed the informed consent

Exclusion criteria

Exclusion Criteria:

  • Those who have special food requirements or having a history of food allergies
  • Those who have history of previous diabetes, or body weight loss, BMI ≤ 18
  • Those who have had cardiovascular and cerebrovascular events within half a year, or who have a major history of surgery
  • Pregnant or lactating woman
  • Those who have severe primary diseases such as liver or kidney diseases, as well as abnormalities in the hematopoietic system and mental disorders
  • Those who need to take special drugs (such as hormones)
  • Those who refuse to provide information required for research (such as personal information, blood samples, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    TCM-FMD

    Fasting-Mimicking Diet Combined With a "Dispelling Dampness" Meal Replacement Apply fastening-mimicking diet combined with a "dispelling dampness" meal replacement. For the convenience of implementation, a cycle of 4 weeks. The first 5 days of each cycle is the calorie restriction stage (daily calorie about 800kcal). The traditional Chinese medicine with dampness effect is used as the main source of calories in this stage. The normal diet is carried out under the guidance of a professional dietitian for the next 23 days. Study for 12 weeks.

    Device: Fastening-mimicking diet combined with a "dispelling dampness" meal replacement

  • Placebo comparator
    Normal diet

    Carrying out normal diet under the guidance of a dietitian, for 12 weeks.

    Other: Normal diet

Interventions

  • DeviceFastening-mimicking diet combined with a "dispelling dampness" meal replacement

    Apply fastening-mimicking diet combined with a "dispelling dampness" meal replacement. For the convenience of implementation, a cycle of 4 weeks. The first 5 days of each cycle is the calorie restriction stage (daily calorie about 800kcal). The traditional Chinese medicine with dampness effect is used as the main source of calories in this stage. The normal diet is carried out under the guidance of a professional dietitian for the next 23 days. Study for 12 weeks.

  • OtherNormal diet

    Carrying out normal diet under the guidance of a dietitian.

06

What researchers measure

Primary outcomes

  1. Gut microbiota Gut microbiota

    Changes in the diversity and abundance of intestinal flora, the number of Firmicutes, Bacteroides and the ratio of Firmicutes/Bacteroides

    Time frame: Change from baseline to week 12

Secondary outcomes

  1. Body morphology indicators

    Changes in body morphology indicators (weight, BMI, waist circumference, body fat percentage, skeletal muscle weight, etc.)

    Time frame: Change from baseline to week 12

  2. Fasting glucose

    Changes in fasting blood glucose

    Time frame: Change from baseline to week 12

  3. Blood pressure

    Changes in blood pressure

    Time frame: Change from baseline to week 12

  4. Blood lipids

    Changes in blood lipids

    Time frame: Change from baseline to week 12

07

Study locations

2 of 2 sites recruiting
  • Yuanqi physical Zhao
    Guangzhou, Guangdong, China
    Enrolling by invitation
  • Yuanqi physical Zhao
    Guangzhou, Guangdong, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2021 (actual). Primary completion is estimated for Nov 2021, 3 months after the start.

Of 2,256 non-industry interventional studies with no phase under Obesity, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's planned 3 months is below that.

Counting every sponsor, half of 2,355 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2020
First posted
Feb 10, 2020
StartActual
Jul 21, 2021
Primary completionEst.
Nov 12, 2021
CompletionEst.
Feb 12, 2022
Last update
Oct 12, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04261764
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Responsible party
Yuanqi Zhao,MD (Principal Investigator, Guangdong Provincial Hospital of Traditional Chinese Medicine) — Principal investigator
First posted
Feb 10, 2020
Start date
Jul 21, 2021
Primary completion
Nov 12, 2021 (estimated)
Completion
Feb 12, 2022 (estimated)
Last update
Oct 12, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion